Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: Relative frequency, risk factors, antimicrobial resistance and treatment

Infection

Volumn 36, Issue 5, 2008, Pages 421-426

  Marcus, N ^a   Ashkenazi, S ^a,c   Samra, Z ^b   Cohen, A ^d   Livni, G ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Community Children's Health Center ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; COMMUNICABLE DISEASE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HOSPITALIZED CHILD; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; TERTIARY HEALTH CARE; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALIZATION; HOSPITALS, COMMUNITY; HUMANS; INFANT; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 56549084176     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-7328-4     Document Type: Article

References (27)

1. Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D: Prevalence of urinary tract infection in febrile infants. J Pediatr 1993; 123: 17-23.
2. Zorc JJ, Kiddoo DA, Shaw KN: Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 2005; 18: 417-422.
3. Schlager TA: Urinary tract infections in infants and children. Infect Dis Clin North Am 2003; 17: 353-365.
4. Elder JS: Urologic disorders in infants, children. In: Behrman RE, Kliegman RM, Jenson HB (eds): Nelson textbook of pediatrics (17th edn). WB Saunders, Philadelphia 2004, pp 1785-1790.
5. Craig JC, Irwig LM, Knight JF, Sureshkumar P, Roy LP: Symptomatic urinary tract infection in preschool Australian children. J Paediatr Child Health 1998; 34: 154-159.
6. Ashkenazi S, Even-Tov S, Samra Z, Dinari G: Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J 1991; 10: 742-746.
7. Hellerstein S: Urinary tract infections: old and new concepts. Pediatr Clin North Am 1996; 42: 1433-1457.
8. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Kearney DH, Reynolds EA, Ruley J, Janosky JE: Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999; 104: 79-86.
9. Ronald A: The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49: 71-82.
10. Alper BS, Curry SH: Urinary tract infection in children. Am Fam Physician 2005; 72: 2483-2488.
11. Winter AL, Hardy BE, Alton DJ, Arbus GS, Churchill BM: Acquired renal scars in children. J Urol 1983; 129: 1190-1194.
12. Committee on Quality Improvement, Subcommittee on Urinary Tract Infections. Practice parameter: the diagnosis, treatment, and evaluation of the initial UTI in febrile infants and young children. Pediatrics 1999; 103: 843-852.
13. Bagga A, Babu K, Kanitkar M, Srivastava RN: Consensus statement on management of urinary tract infections. Indian Pediatr 2001; 38: 1106-1115.
14. Haller M, Brandis M, Berner R: Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol 2004; 19: 982-986.
15. Gupta K: Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003; 17: 243-259.
16. Marcus N, Ashkenazi S, Yaari A, Samra Z, Livni G: Non-Escherichia coli versus Eschericia coli community acquired urinary tract infection in children hospitalized in a tertiary center. Relative frequency, risk factors, antimicrobial resistance and outcome. Pediatr Infect Dis J 2005; 7: 581-585.
17. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Fourth Informational Supplement. NCCLS Document M7-A3. Villanova, PA. Clinical and Laboratory Standards Institute, 1994.
18. Mangiarotti P, Pizzini C, Fanos V: Antibiotic prophylaxis in children with relapsing urinary tract infections: review. J Chemother 2000; 12: 115-123.
19. Schalager TA: Urinary tract infections in children younger than 5 years of age: epidemiology, diagnosis, treatment, outcome and prevention. Paediatr Drugs 2001; 3: 219-227.
20. Santen SA, Altieri MF: Pediatric urinary tract infection. Emerg Med Clin North Am 2001; 19: 675-690.
21. Prais D, Straussberg R, Avitzur Y, Nussinovitch M, Harel L, Amir J: Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 2003; 88: 215-218.
22. Sakran W, Miron D, Halevy R, Colodner R, Smolkin V, Koren A: Community acquired urinary tract infection among hospitalized children in northern Israel: pathogens, susceptibility patterns and urinary tract anomalies. Harefuah 2003; 142: 249-252.
23. Allen UD, MacDonald N, Fuite L, Chan F, Stephens D: Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. J Am Med Child 1999; 160: 1436-1440.
24. Howard AJ, Magee JT, Fitzgerald KA, Dunstan FDJ: Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales. J Antimicrob Chemother 2001; 47: 305-313.
25. Ladhani S, Gransden W: Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003; 88: 444-445.
26. Wright SW, Wren KD, Haynes ML: Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999; 14: 606-609.
27. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L: Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006; 117: 626-632.